People · Operator

Steven Elkes

Named in public records as an officer, director or promoter · active 2010–2021 · Other Technology

2
Companies
10
Filings
$17.2M
Combined raised · real
Serial
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Surface Travel Inc. d/b/a CuracityOther TechnologySeed$10.5M$66.1M2015
Makeover Solutions, Inc.Other TechnologySeed$6.7M$17.0M2010
Operator network

Steven Elkes at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Matthew McCooe · 5 companies · 1 sharedMatthew McCooeRobert Nolan · 4 companies · 1 sharedRobert NolanJoseph Apprendi · 3 companies · 1 sharedJoseph ApprendiMichael Keriakos · 3 companies · 1 sharedMichael KeriakosWilliam Peabody · 2 companies · 1 sharedWilliam PeabodyHAIDER B. AKMAL · 1 companies · 1 sharedHAIDER B. AKMALMATTHEW B. MCCOOE · 1 companies · 1 sharedMATTHEW B. MCCOOETHOMAS B. MANGAS · 1 companies · 1 sharedTHOMAS B. MANGASDouglas McCormick · 3 companies · 1 sharedDouglas McCormickWilliam Bo Peabody · 2 companies · 1 sharedWilliam Bo PeabodyAlvin Chan · 1 companies · 1 sharedAlvin ChanJeffrey Grammer · 1 companies · 1 sharedJeffrey GrammerSurface Travel Inc. d/b/a Curacity · $10.5M raisedSurface Travel Inc. d…Makeover Solutions, Inc. · $6.7M raisedMakeover Solutions, I…Steven ElkesSE
Steven Elkes Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Steven Elkes on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Matthew McCooe15
Robert Nolan14
Douglas McCormick13
Joseph Apprendi13
Michael Keriakos13
William Peabody12
William Bo Peabody12
Jeffrey Grammer11
HAIDER B. AKMAL11
THOMAS B. MANGAS11
MATTHEW B. MCCOOE11
Alvin Chan11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.